Xu, K. Y., Huang, V., Williams, A. R., Martin, C. E., Bazazi, A. R., & Grucza, R. A. (2023). Co-occurring psychiatric disorders and disparities in buprenorphine utilization in opioid use disorder: An analysis of insurance claims. Drug and Alcohol Dependence Reports, 9, 100195. https://doi.org/10.1016/j.dadr.2023.100195

Zollweg, S. S., Belloir, J. A., Drabble, L. A., Everett, B., Taylor, J. Y., & Hughes, T. L. (2023). Structural stigma and alcohol use among sexual and gender minority adults: A systematic review. Drug and Alcohol Dependence Reports, 8, 100185. https://doi.org/10.1016/j.dadr.2023.100185

Raby, W. N., Heller, M., Milliaressis, D., Choi, C. J., Basaraba, C., Levin, F. R., Church, S., Pavlicova, M., & Nunes, E. V. (2023). Cocaine use disorder patients develop distinct patterns of regulation of acth secretion by a vasopressin agonist and oxytocin: Report on a laboratory study. Drug and Alcohol Dependence Reports, 7, 100158. https://doi.org/10.1016/j.dadr.2023.100158

Walsh, C. A., Struble, C. A., Aharonovich, E., Shmulewitz, D., Borodovsky, J., Habib, M. I., Budney, A., Livne, O., & Hasin, D. S. (2023). Evaluating cannabis exposure in survey items: Insights, strategies, and remaining challenges identified from cognitive interviewing. Drug and Alcohol Dependence Reports, 7, 100161. https://doi.org/10.1016/j.dadr.2023.100161

Silwal, A., Talbert, J., Bohler, R. M., Kelsch, J., Cook, C., Blevins, D., Gallivan, M., Hunt, T., Hatcher, S. M., Thomas, C. P., Williams, S., Fanucchi, L., & Lofwall, M. R. (2023). State alignment with federal regulations in 2022 to relax buprenorphine 30-patient waiver requirements. Drug and Alcohol Dependence Reports, 7, 100164. https://doi.org/10.1016/j.dadr.2023.100164

Sosnowski, D. W., Jaffe, A. E., Tao, R., Deep-Soboslay, A., Shu, C., Sabunciyan, S., Kleinman, J. E., Hyde, T. M., & Maher, B. S. (2022). Differential expression of NPAS4 in the dorsolateral prefrontal cortex following opioid overdose. Drug and Alcohol Dependence Reports, 3, 100040. https://doi.org/10.1016/j.dadr.2022.100040

Struble, C. A., Borodovsky, J. T., Habib, M. I., Hasin, D. S., Shmulewitz, D., Livne, O., Walsh, C., Aharonovich, E., & Budney, A. J. (2022). Cannabis practices among a gender-diverse sample of young adults. Drug and Alcohol Dependence Reports, 5, 100113. https://doi.org/10.1016/j.dadr.2022.100113

Ankrum, H., Kreski, N. T., Cerdá, M., Chen, Q., Hasin, D. S., Martins, S. S., Miech, R., Olfson, M., & Keyes, K. M. (2022). Co-substance use of nicotine vaping and non-cigarette tobacco products among U.S. grade 12 students from 2017-2019. Drug and Alcohol Dependence Reports, 5, 100112. https://doi.org/10.1016/j.dadr.2022.100112

Tomko, C., Olfson, M., & Mojtabai, R. (2022). Gaps and barriers in drug and alcohol treatment following implementation of the affordable care act. Drug and Alcohol Dependence Reports, 5, 100115. https://doi.org/10.1016/j.dadr.2022.100115

Pan, Y., Feaster, D. J., Odom, G., Brandt, L., Hu, M.-C., Weiss, R. D., Rotrosen, J., Saxon, A. J., Luo, S. X., & Balise, R. R. (2022). Specific polysubstance use patterns predict relapse among patients entering opioid use disorder treatment. Drug and Alcohol Dependence Reports, 5, 100128. https://doi.org/10.1016/j.dadr.2022.100128

Hefner, K., Choo, T.-H., Shmueli-Blumberg, D., Pavlicova, M., King, J., Fishman, M., Shulman, M., Campbell, A., Greiner, M., Scodes, J., Meyers-Ohki, S., Novo, P., Nunes, E., & Rotrosen, J. (2022). Time-lagged association between counseling and/or 12-Step attendance with subsequent opioid use in a secondary analysis from a randomized, clinical trial of medications for opioid use disorder. Drug and Alcohol Dependence Reports, 5, 100100. https://doi.org/10.1016/j.dadr.2022.100100

Morgan, J. R., Freibott, C. E., Jalali, A., Jeng, P. J., Walley, A. Y., Chatterjee, A., Green, T. C., Nolan, M. L., Linas, B. P., Marshall, B. D. L., & Murphy, S. M. (2022). The role of increasing pharmacy and community distributed naloxone in the opioid overdose epidemic in Massachusetts, Rhode Island, and New York City. Drug and Alcohol Dependence Reports, 4, 100083. https://doi.org/10.1016/j.dadr.2022.100083

Rudolph, K. E., Russell, M., Luo, S. X., Rotrosen, J., & Nunes, E. V. (2022). Under-representation of key demographic groups in opioid use disorder trials. Drug and Alcohol Dependence Reports, 4, 100084. https://doi.org/10.1016/j.dadr.2022.100084

Drabble, L. A., Munroe, C., Mericle, A. A., Zollweg, S., Trocki, K. F., & Karriker-Jaffe, K. J. (2022). Impact of the policy environment on substance use among sexual minority women. Drug and Alcohol Dependence Reports, 3, 100058. https://doi.org/10.1016/j.dadr.2022.100058

Keyes, K. M., Rutherford, C., Hamilton, A., Barocas, J. A., Gelberg, K. H., Mueller, P. P., Feaster, D. J., El-Bassel, N., & Cerdá, M. (2022). What is the prevalence of and trend in opioid use disorder in the United States from 2010 to 2019? Using multiplier approaches to estimate prevalence for an unknown population size. Drug and Alcohol Dependence Reports, 3, 100052. https://doi.org/10.1016/j.dadr.2022.100052

Noël Raby, W., Heller, M., Milliaressis, D., Jean Choi, C., Basaraba, C., Pavlicova, M., Alschuler, D. M., Levin, F. R., Church, S., & Nunes, E. V. (2022). Intranasal oxytocin may improve odds of abstinence in cocaine-dependent patients: results from a preliminary study. Drug and Alcohol Dependence Reports, 2, 100016. https://doi.org/10.1016/j.dadr.2021.100016